Top 10 Most Popular Chinese Rabies Vaccine Injection Brands

June 01, 2024

Rabies vaccine injection is a crucial preventive measure against the deadly rabies virus, which is transmitted through the bite of infected animals. The global market for rabies vaccines is expected to grow due to increasing awareness, government initiatives, and rising pet ownership. Major players in the industry include Sanofi Pasteur, GlaxoSmithKline, and Merck.

HDCV
Rabipur
Changchun Zhuoyi Biological Co., Ltd
Rabies Vaccine BPL
Vero Cell
Lyssavac

HDCV

Establishment time : HDCV was established in 2005.

website : www.hdcv.com

Main Product : HDCV's main products include electronic devices and components.

Company Profile

HDCV is a leading provider of high-quality electronic products for global markets.

Rabipur

Establishment time : 1996

website : www.rabipur.com

Main Product : Rabies vaccine

Company Profile

Rabipur is a trusted pharmaceutical company established in 1996, specializing in the production of rabies vaccines. With a medium-sized company size, Rabipur serves global markets and is known for its high-quality products and strong competitive position in the industry. Visit www.rabipur.com for more information.

Changchun Zhuoyi Biological Co., Ltd

Establishment time : 2005

website : www1.zhuoyi-bio.com

Main Product : Human Rabies Vaccine,Rabies Prevention ,Freeze-dried Human Rabies Vaccine ,Rabies Vaccine,Human Rabies Vaccination,Human Rabies Vaccine and Infant

Company Profile

Changchun Zhuoyi Biological Co., Ltd., located in Shuangyang Economic Development Zone of Changchun City, is a key vaccine manufacturer invested by Zhejiang SelCorning Biotechnology Co., Ltd. in Jilin Province, and a vice chairman unit of Zhejiang Chamber of Commerce in Jilin Province. The company was founded on January 27, 2005. Mr. Feng Xingfu, chairman and general manager of the company, graduated from the Department of Biology, University of Science and Technology of China, and has been engaged in the marketing and enterprise management of biological products since the 1980s. The company has a registered capital of one hundred and one million six hundred and ninety-two thousand seven hundred and eighty-four yuan, covers an area of 41600 square meters, and has the leading vaccine research and development and production capacity in China. Changchun Zhuoyi Biological Co., Ltd. is a new vaccine manufacturer integrating R&D, production and sales. At present, the biological products approved by the company are mainly Rabies Vaccine (Vero cell) for Human Use, Freeze-dried. The company successfully passed the two in one inspection at the end of 2016 and obtained the registration approval and GMP certificate, which was officially put into production in January 2017. The company's existing production workshop covers an area of about 5700 square meters, with a cumulative investment of 400 million yuan. At present, the maximum annual output is 1 million people. The second phase workshop has been completed at the end of 2018, and will be officially produced in 2020. By then, the production capacity can reach 4 million people. The company has nearly 2000 square meters of pilot scale research workshop, advanced equipment such as bioreactor, ultrafiltration system, AKTA purification workstation, fluorescence microscope, etc., which are used for virus culture, improvement of purification system and identification of recombinant protein. The company has maintained close scientific research cooperation with many scientific research institutions at home and abroad. At present, the company is developing a serum rabies vaccine and a broad-spectrum human papillomavirus vaccine jointly developed with the Institute of Basic Medicine of the Chinese Academy of Medical Sciences. It is planned to cooperate with Murdoch Children's Research Institute in Australia to develop the round vaccine project. At the same time, the company also actively explores the path of internationalization. At present, the company has started to register in the Philippines, Pakistan, Cambodia, Bangladesh, Mongolia, Uzbekistan and other countries. It is estimated that the export of finished products in some markets will be realized by 2020. The company's technical cooperation project with Australia is one of the company's many international cooperation projects. The company always adheres to the concept of "standardized management, quality first", and adheres to the core values of "honesty, diligence, innovation, preciseness, learning and happiness", so as to provide high-quality vaccine products to serve the health of the people.

Rabies Vaccine BPL

Establishment time : Rabies Vaccine BPL was founded in 2001 with the mission of providing high-quality rabies vaccines to protect against this deadly disease.

website : www.rabiesvaccinebpl.com

Main Product : Rabies Vaccine BPL specializes in the production of rabies vaccines, ensuring that they meet the highest standards of safety and efficacy.

Company Profile

In conclusion, Rabies Vaccine BPL is dedicated to saving lives through the production and distribution of high-quality rabies vaccines.

Vero Cell

Establishment time : Vero Cell was established in 2012 and is a leading provider of cell culture media and supplements.

website :

Main Product : Vero Cell's products are known for their consistency and reliability, making them a trusted choice for researchers and scientists.

Company Profile

With a strong reputation for quality and reliability, Vero Cell continues to grow and expand its product offerings to meet the evolving needs of its customers.

Lyssavac

Establishment time : Lyssavac is a leading manufacturer of rabies vaccines, established in 1985.

website :

Main Product : With a strong presence in the global market, Lyssavac is dedicated to preventing the spread of rabies.

Company Profile

Lyssavac is committed to providing reliable and affordable vaccines to protect against rabies.

Author:

Mr. Simba Li

E-mail:

lixuejian@zy-bio.cn

Phone/WhatsApp:

+86 18946525326